Gruia
Dumitru Gruia, San Ramon, CA US
Patent application number | Description | Published |
---|---|---|
20080298803 | SYSTEM AND METHOD FOR PROTECTION OF POINT TO MULTIPOINT PASSIVE OPTICAL NETWORK - A system and method relating to a point-to-multipoint Passive Optical Network (PON) that protects the system against fiber breaks or damage which can disrupt the path between the OLT and a plurality of Dual Transceiver ONUs. | 12-04-2008 |
Gabriela Gruia, Hoboken, NJ US
Patent application number | Description | Published |
---|---|---|
20100273719 | USE OF SOMATOSTATIN ANALOGS IN MENINGIOMA - The present invention relates to the use of a Somatostatin (SRIF) analog which has a high binding affinity to human SSTR1,2,3,5, or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical composition for the treatment of meningioma. | 10-28-2010 |
20120302500 | USE OF SOMATOSTATIN ANALOGS IN MENINGIOMA - The present invention relates to the use of a Somatostatin (SRIF) analog which has a high binding affinity to human SSTR1,2,3,5, or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical composition for the treatment of meningioma. | 11-29-2012 |
20130303450 | USE OF SOMATOSTATIN ANALOGS IN MENINGIOMA - The present invention relates to the use of a Somatostatin (SRIF) analog which has a high binding affinity to human SSTR1,2,3,5, or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical composition for the treatment of meningioma. | 11-14-2013 |
Harel Gruia, Moshav Ganot IL
Patent application number | Description | Published |
---|---|---|
20110010628 | Method and Apparatus for Automatic Annotation of Recorded Presentations - Automatic annotation of recorded lectures includes the annotation of recorded presentations as presented on a computer screen during a presentation. Such annotation is accomplished with metadata that indicates the original slide and the time in the presentation that the slide was presented. Registration of the presentation tags the presentation with this metadata, which uniquely identifies the presentation and each slide. The metadata enables future searching of the recorded presentation for the annotation, such that segments of recorded presentations in which the slide was presented can be recalled. The searching function can also be used in an integrated system with other applications to enable recall of segments of relevant recorded presentations. | 01-13-2011 |
Harel Gruia, Qiryat Tiyon IL
Patent application number | Description | Published |
---|---|---|
20090172714 | METHOD AND APPARATUS FOR COLLECTING METADATA DURING SESSION RECORDING - Text that appears in sessions presented on a computer screen is indexed to enable future text-based search of the session content. During the recording, a text capture algorithm is used to capture any text data presented on any window on the computer screen, either in a selective or in an all-encompassing manner. Data captured are indexed to the capture time because a timestamp must be known to allow for a search that can provide temporal relevance. The interval used to capture the window data is modifiable, based on the needs of the application. Once the window is scanned, a comparison is done with the results of previous captures to determine if there is a need to update the metadata database with new results. | 07-02-2009 |
Iuliana Gruia, Bucharest RO
Patent application number | Description | Published |
---|---|---|
20080213390 | Deuterium Depleted Water (Ddw) Using As Adjuvant In Cancer Therapy For Cytostatics Toxicity Reducing - A method is provided for utilizing Deuterium Depleted Water (DDW) as an adjuvant in cancer therapy and for reducing cytostatic toxicity. The method includes administration of DDW having a concentration of about 60 ppm, as a daily diet, to animals. The cancer therapy can include a mono-chemotherapy where a single drug or cytostatic is used or a poly-chemotherapy where more than one drug or cytostatic is used. The drug or cytostatic that are used for chemotherapy can include one or more of Cyclophosphamide, 5-Flourouracil, Farmarubicine and Vinblastine. The method can be used to treat different types of cancer. | 09-04-2008 |